Population pharmacokinetics and safety of piperacillin-tazobactam extended infusions in infants and children
C Thibault, J Lavigne, C Litalien, N Kassir… - Antimicrobial agents …, 2019 - Am Soc Microbiol
Piperacillin-tazobactam (TZP) is frequently used to treat severe hospital-acquired infections
in children. We performed a single-center, pharmacokinetic (PK) trial of TZP in children …
in children. We performed a single-center, pharmacokinetic (PK) trial of TZP in children …
[HTML][HTML] A new framework to implement model-informed dosing in clinical guidelines: piperacillin and amikacin as proof of concept
SJF Hartman, JGE Swaving, SW Van Beek… - Frontiers in …, 2020 - frontiersin.org
Background: Modeling and simulation is increasingly used to study pediatric
pharmacokinetics, but clinical implementation of age-appropriate doses lags behind …
pharmacokinetics, but clinical implementation of age-appropriate doses lags behind …
Optimisation des traitements pharmacologiques chez les enfants atteints de sepsis
C Thibault - 2022 - papyrus.bib.umontreal.ca
Le sepsis sévère est l'une des causes de mortalité les plus fréquentes à travers le monde.
L'étiologie la plus fréquente étant des infections causées par des bactéries, le traitement …
L'étiologie la plus fréquente étant des infections causées par des bactéries, le traitement …